COMPNAY REPORTS - ChangeWave

Yet, the world relies largely on the biggest pharmaceutical companies for molecular development that will battle both perennial and increasingly threatening diseases. On 18 April the “Patent Reform Act 2007” came into force in the USA. ... The build up of inventory is a constant problem in the industry, particularly in the big pharma ... ................
................